Senior Legal Counsel, Isomorphic Labs
London
More information about location
3+ days a week in office
AI-driven drug discovery and development
Be an early applicant
AI-driven drug discovery and development
101-200 employees
Be an early applicant
More information about location
3+ days a week in office
101-200 employees
Company mission
Isomorphic Labs' mission is to use AI and machine learning methods to accelerate and improve the drug discovery process.
Role
Who you are
- Experience managing legal operations, with a speciality in drug discovery and CRO transactions strongly preferred
- BA/BS/LLB/JD degree or equivalent
- UK or US-qualified attorney/solicitor, with 3+ years’ post-qualified experience in private practice and/or on an in-house team
- Willingness and ability to work collaboratively with colleagues and IsoLegal Team members on a broad range of legal matters
- Strong analytical and organisational skills
- Demonstrated ability to grasp legal, scientific and technical concepts quickly
- Ability to prioritise, work independently and manage numerous simultaneous projects under deadline pressure
Desirable
- Prior in-house experience at a technology and/or research-focused organisation working side by side with the wider company stakeholders to provide counsel on a variety of legal issues
- Experience presenting and influencing at executive level
- Desire and ability to identify flexible, creative solutions to complex and difficult challenges, and work in a high-ambiguity, high-change environment
- Experience in one of the following areas of law: employment, privacy, transactions
What the job involves
- As Senior Legal Counsel, you will directly impact the company’s future by working closely with, and advising, our AI, Drug Design and commercial teams
- This role will report directly to the General Counsel and provide a unique opportunity to help shape Isomorphic’s legal function
- As a member of the IsoLegal team, you will balance strategic contributions with practical tasks, and will build trusted relationships with leaders, using your knowledge and influencing skills to shape how we build and develop Isomorphic’s business from a legal perspective
- There is some degree of flexibility around the level of seniority in this position depending on your skills and experience
- Review, draft, manage and advise on a range of agreements such as NDAs, material transfer agreements, data licence agreements, R&D agreements, inbound services agreements, collaboration agreements, consulting agreements, and employment agreements
- Advise the business on ad hoc legal queries in a timely manner, including summarising and communicating legal concepts and helping assess different levels of legal risk
- Build positive relationships with business clients across our offices to understand and manage enterprise risks, streamline contracting processes and ensure effective collaboration with IsoLegal
- Help establish, maintain and improve our standard form agreements, legal and compliance processes and legal operations
- Deal with evolving areas of law including corporate/commercial, data privacy, technology, sanctions and regulatory compliance
Salary benchmarks
Our take
The discovery of new drugs is essential for medical innovations, but the process is lengthy, high-risk, and expensive. This is due to manual research and analysis processes that are prone to human error and time-consuming workflows, raising the question as to whether AI could reduce these pitfalls.
Rather than bolting ML onto the existing drug discovery process, Isomorphic Labs is reimagining everything from first principles with an AI-first approach, leveraging machine learning to build predictive and generative models of biological phenomena to understand how novel drugs could perform. The company differentiates itself from other AI-driven drug discovery startups by being a direct subsidiary of Alphabet, with access to resources, computing power, and partnerships with teams within DeepMind.
AI-driven drug discovery itself may not be novel, but the approach the company is taking, as well as its direct links with Alphabet, Google, and DeepMind present great potential for the company to disrupt the market with the best talent and technology. For example, 2023 saw Isomorphic and DeepMind unveil Alphafold 3, an AI model that has the ability to predict the complex molecular structures of life's foundational building blocks, further adding to the anticipation in the industry for Isomorphic's future work.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
Company
Company values
- Thoughtful: Thoughtful at Iso is about curiosity, creativity and care. It is about good people doing good, rigorous and future-making science every single day
- Brave: Brave at Iso is about fearlessness, but it’s also about initiative and integrity. The scale of the challenge demands nothing less
- Determined: Determined at Iso is the way we pursue our goal. It’s a confidence in our hypothesis, as well as the urgency and agility needed to deliver on it. Because disease won’t wait, so neither should we
- In this together: Together at Iso is about connection, collaboration across fields and catalytic relationships. It’s knowing that transformation is a group project, and remembering that what we’re doing will have a real impact on real people everywhere
Company HQ
London, UK
Articles
Leadership
Demis Hassabis
(CEO)Experience as Founder & CEO of Elixir Studios. Founder and CEO of DeepMind since 2010.
Share this job
View 2 more jobs at Isomorphic Labs